2025-10-19 - Analysis Report
Okay, here's an analysis of Intuitive Surgical (ISRG) based on the provided data, presented in a structured format:

## ISRG Stock Analysis

**Company Overview:** Intuitive Surgical Inc. designs, manufactures, and markets the da Vinci surgical system and related instruments and accessories.

### 1. Performance vs. S&P 500 (VOO)

*   **ISRG Cumulative Return:** 66.19%
*   **VOO Cumulative Return:** 97.05%
*   **Absolute Deviation:** -33.9%
*   **Deviation Range (Max: 98.9, Min: -37.8):**
*   **Relative Deviation:** 2.9

**Analysis:** ISRG has significantly underperformed the S&P 500 over the period reflected in the cumulative return data. The negative absolute deviation highlights this underperformance. The relative deviation of 2.9 suggests that the current deviation is near the lower end of its historical range compared to the S\&P 500.

**Alpha, Beta Analysis:**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 68.0% | 77.6% | 40.0% | -0.1 | 43.6 |
| 2016-2018  | 64.0% | 72.2% | 49.0% | -0.0 | 57.2 |
| 2017-2019  | 54.0% | 72.2% | 31.0% | 0.2 | 70.6 |
| 2018-2020  | -6.0% | 80.4% | -29.0% | 0.3 | 97.8 |
| 2019-2021  | 29.0% | 80.4% | -18.0% | 0.6 | 128.8 |
| 2020-2022  | -23.0% | 80.4% | -22.0% | 1.2 | 95.1 |
| 2021-2023  | -17.0% | 77.5% | -18.0% | 1.7 | 120.9 |
| 2022-2024  | 36.0% | 77.5% | 15.0% | 1.7 | 187.1 |
| 2023-2025  | 28.0% | 72.7% | -33.0% | 0.8 | 159.9 |

**Analysis:**

*   **CAGR:** Varies significantly across periods, indicating volatility in growth.
*   **MDD:** Consistently high Maximum Drawdown values indicate substantial risk.
*   **Alpha:**  Alpha is inconsistent, sometimes positive and sometimes negative, meaning that it does not consistently generate excess returns.
*   **Beta:** Beta has generally increased over time. Higher Beta values indicate that the stock has become more sensitive to market movements.
*   **Cap:** Market capitalization has generally increased over the years.

### 2. Recent Price Action

*   **Current Price:** 446.13
*   **Previous Close:** 434.62
*   **Change:** 2.65%
*   **5-day Moving Average:** 437.70
*   **20-day Moving Average:** 441.65
*   **60-day Moving Average:** 459.63

**Analysis:** The stock price has increased significantly compared to the previous close, indicating a strong recent upward movement. However, the current price is still below the 60-day moving average, suggesting potential resistance at that level. The price is above the 5-day and 20-day moving averages, reflecting short-term positive momentum.

### 3. Technical Indicators

*   **Market Risk Indicator (MRI):** 0.5 (Low Investment)
*   **RSI:** 50.98 (Neutral)
*   **PPO:** 0.22 (Neutral)
*   **Hybrid Signal:** cash_0%_Buy 100% of cash
*   **Delta_Previous_Relative_Divergence:** 2.2 (+) (Short-term increase)
*   **Expected Return:** 429.6%

**Analysis:**

*   **MRI:** A value of 0.5 suggests a "Low Investment" recommendation, indicating moderate risk.
*   **RSI:**  An RSI around 50 is neutral, meaning the stock isn't overbought or oversold.
*   **PPO:** A slightly positive PPO value indicates a weak upward trend, suggesting that the shorter-term moving average is slightly above the longer-term moving average.
*   **Delta:** The positive Delta suggests short-term upward momentum.
*   **Expected Return:** The very high expected return (429.6%) is an outlier and should be viewed with extreme caution. It represents the model's estimation of future returns based on the provided data.

### 4. Recent News & Significant Events

*   **Motley Fool:**  Suggests ISRG as a growth stock.
*   **Insider Monkey:** Jim Cramer is negative on ISRG.
*   **Wall Street Journal:** Mentions upcoming events that could impact the stock.
*   **Zacks:**  Analyzing whether to buy, hold, or sell ISRG.
*   **Insider Monkey:** Highlights Wall Street's bullish sentiment.
*   **Motley Fool:** Suggests alternative medical device stocks.

**Analysis:** The news is mixed. Some sources suggest potential for growth, while others are more cautious or suggest alternatives. Jim Cramer's negative sentiment is noteworthy.

### 4-2) Analyst Opinions

*   **Consensus:** Buy (Mean: 1.94)
*   **Target Price:** 568.40 (Average)
*   **Opinions:** 27

**Analysis:** The analyst consensus is "Buy," with a significant upside potential based on the average target price.

### 5. Recent Earnings Analysis

| 날짜       | EPS  | 매출      |
|------------|------|-----------|
| 2025-07-23 | 1.84 | 2.44 B$   |
| 2025-04-23 | 1.95 | 2.25 B$   |
| 2024-10-18 | 1.59 | 2.04 B$   |
| 2024-07-19 | 1.48 | 2.01 B$   |
| 2025-07-23 | 1.48 | 2.01 B$   |

**Analysis:**  EPS and Revenue have generally increased over the last few quarters, indicating growth.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter    | Revenue  | Profit Margin |
|------------|----------|---------------|
| 2025-06-30 | \$2.44B  | 66.31%        |
| 2025-03-31 | \$2.25B  | 64.69%        |
| 2024-12-31 | \$2.41B  | 68.04%        |
| 2024-09-30 | \$2.04B  | 67.41%        |
| 2024-06-30 | \$2.01B  | 68.30%        |

**Capital and Profitability:**

| Quarter    | Equity    | ROE     |
|------------|-----------|---------|
| 2025-06-30 | \$17.85B  | 3.69%   |
| 2025-03-31 | \$17.11B  | 4.08%   |
| 2024-12-31 | \$16.43B  | 4.17%   |
| 2024-09-30 | \$15.58B  | 3.63%   |
| 2024-06-30 | \$14.71B  | 3.58%   |

**Analysis:** Revenue and profit margins are strong. Equity is increasing, but ROE has fluctuated.

### 7. Overall Summary

**Key Takeaways:**

*   **Underperformance:** ISRG has significantly underperformed the S&P 500.
*   **Mixed Sentiment:** News and analyst opinions are mixed, with some positive and some negative outlooks.
*   **Recent Momentum:** The stock has shown recent upward momentum.
*   **Strong Fundamentals:** Revenue, profit margins, and equity are generally strong.
*   **High Volatility:**  The maximum drawdown and Beta values are very high, indicating substantial risk.

**Conclusion:**

ISRG presents a mixed investment picture. While the company has strong fundamentals and recent earnings suggest growth, its underperformance relative to the S&P 500 and high volatility are concerning. Analyst opinions are generally positive, but recent news highlights concerns. Investors should weigh these factors carefully and consider their risk tolerance before investing. The extremely high expected return should be treated with skepticism.
